Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiplatelet Therapies in Psoriasis
NCT07744191Phase 4Not yet recruiting
- Sponsor
- NYU Langone Health
- Start
- Sep 2026
- Primary completion
- Sep 2031
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel in psoriasis, psoriatic arthritis (PsA), sponsored by NYU Langone Health. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
clopidogrel
03
Conditions
psoriasispsoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT07744191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07744191.